Cohen Amir 4
4 · Strata Critical Medical, Inc. · Filed Feb 26, 2026
Research Summary
AI-generated summary of this filing
Strata (SRTA) Chief Accounting Officer Receives RSU Award
What Happened
Amir Cohen, Chief Accounting Officer of Strata Critical Medical, was granted 64,191 restricted stock units (RSUs) on February 24, 2026. The grant is recorded at $0.00 per share (no cash was paid at grant). This is an equity award (not an open‑market purchase or sale).
Key Details
- Transaction date: February 24, 2026; Form 4 filed February 26, 2026 (timely filing).
- Grant: 64,191 RSUs, acquisition price $0.00 (value at grant reported as $0).
- Shares owned after transaction: not disclosed in the filing.
- Footnote: RSUs will settle into common shares upon vesting. 6.25% of the RSUs (rounded down) vest every three months after March 8, 2026; any remaining unvested RSUs vest on March 8, 2030, subject to continued service.
Context
RSUs are a form of compensation that convert into actual shares only as they vest; they do not require an immediate cash outlay and are not the same as an insider purchase. Grants like this are common for employee retention and compensation and should not be read as a direct buy/sell market signal.
Insider Transaction Report
Form 4
Cohen Amir
Chief Accounting Officer
Transactions
- Award
Class A common stock, $0.0001 par value per share
[F1]2026-02-24+64,191→ 181,817 total
Footnotes (1)
- [F1]Represents a grant of Restricted Stock Units ("RSUs"), which will be settled in shares of the Issuer's common stock upon vesting: 6.25% of the RSUs (rounded down to the nearest whole number) will vest every 3 months after March 8, 2026, with any remaining unvested RSUs to vest on March 8, 2030, subject to the Reporting Person's continued service to the Issuer.
Signature
/s/ Melissa M. Tomkiel, Attorney-in-fact for Amir Cohen|2026-02-26